Astellas Pharma Inc (4503) - Financial and Strategic SWOT Analysis Review

  • ID: 1291539
  • SWOT Analysis
  • 68 pages
  • GlobalData
  • Astellas Pharma, Inc.
1 of 4

FEATURED COMPANIES

  • Eisai Co Ltd
  • Kyowa Hakko Kirin Co Ltd
  • MORE
Astellas Pharma Inc (4503) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights:

Astellas Pharma Inc (Astellas) is one of the leading global pharmaceutical companies, which focuses on the research, development, manufacture and commercialization of a wide range of pharmaceuticals. The company’s product portfolio comprises both marketed and pipeline products for the treatment of a wide range of diseases in the areas of urology, transplantation, immune deficiency, infectious diseases, cancer, neuroscience, and metabolic diseases, among others. The company sells its products under the brand names such as Prograf, Vesicare, Geninax, and Eligard among others. It has operations in several countries across the Americas; Europe, Asia and Oceania through its network of subsidiaries and affiliates. Astellas is headquartered in Tokyo, Japan.

Astellas Pharma Inc Key Recent Developments

Aug 24,2017: Astellas Announces Personnel Changes and Organizational Changes
Jul 28,2017: Astellas Reports First Quarter FY2017 Financial Results
Jul 26,2017: Astellas Announces Wind-Down of Agensys Research Operations
Jul 05,2017: Astellas Named to FTSE4Good Sustainability Index for the Sixth Consecutive Year
Jun 26,2017: Astellas Announces Leadership Promotions in Marketing Strategy and US Commercial Organizations

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Eisai Co Ltd
  • Kyowa Hakko Kirin Co Ltd
  • MORE
Section 1 - About the Company
Astellas Pharma Inc - Key Facts
Astellas Pharma Inc - Key Employees
Astellas Pharma Inc - Key Employee Biographies
Astellas Pharma Inc - Major Products and Services
Astellas Pharma Inc - History
Astellas Pharma Inc - Company Statement
Astellas Pharma Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

Section 2 - Company Analysis
Astellas Pharma Inc - Business Description
Astellas Pharma Inc - Corporate Strategy
Astellas Pharma Inc - SWOT Analysis
SWOT Analysis - Overview
Astellas Pharma Inc - Strengths
Astellas Pharma Inc - Weaknesses
Astellas Pharma Inc - Opportunities
Astellas Pharma Inc - Threats
Astellas Pharma Inc - Key Competitors

Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Astellas Pharma Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments
Aug 24, 2017: Astellas Announces Personnel Changes and Organizational Changes
Jul 28, 2017: Astellas Reports First Quarter FY2017 Financial Results
Jul 26, 2017: Astellas Announces Wind-Down of Agensys Research Operations
Jul 05, 2017: Astellas Named to FTSE4Good Sustainability Index for the Sixth Consecutive Year
Jun 26, 2017: Astellas Announces Leadership Promotions in Marketing Strategy and US Commercial Organizations
Jun 20, 2017: The Astellas Oncology C3 Prize Competition Returns for a Second Year; Aims to Inspire and Support Innovative Ideas for Cancer Care with $100,000 in Grants
Jun 06, 2017: Astellas Announces Record Number of Abstracts Highlighting Breadth and Depth of Oncology Portfolio Data to be Presented at 2017 ASCO Annual Meeting
Jun 05, 2017: Kyoto University and Astellas Inaugurate Alliance Station with Aim of Realizing Advanced Medical Treatments
May 31, 2017: Astellas Announces New Global Website Launch
May 23, 2017: Action On Fistula To Transform 4,500 Lives By 2020
Section 6 - Appendix

Methodology
Ratio Definitions
About the publisher
Contact Us
Disclaimer

List of Tables
Astellas Pharma Inc, Key Facts
Astellas Pharma Inc, Key Employees
Astellas Pharma Inc, Key Employees (cont
Astellas Pharma Inc, Key Employee Biographies
Astellas Pharma Inc, Major Products and Services
Astellas Pharma Inc, History
Astellas Pharma Inc, Other Locations
Astellas Pharma Inc, Subsidiaries
Astellas Pharma Inc, Joint Venture
Astellas Pharma Inc, Key Competitors
Astellas Pharma Inc, Ratios based on current share price
Astellas Pharma Inc, Annual Ratios
Astellas Pharma Inc, Annual Ratios (Cont)
Astellas Pharma Inc, Annual Ratios (Cont)
Astellas Pharma Inc, Interim Ratios
Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Astellas Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Astellas Pharma Inc, Performance Chart (2013 - 2017)
Astellas Pharma Inc, Ratio Charts
Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Astellas Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Takeda Pharmaceutical Company Ltd
  • Taisho Pharmaceutical Holdings Co Ltd
  • Otsuka Pharmaceutical Co Ltd
  • Kyowa Hakko Kirin Co Ltd
  • Eisai Co Ltd
  • Daiichi Sankyo Company Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll